DE60140545D1 - - Google Patents

Info

Publication number
DE60140545D1
DE60140545D1 DE60140545T DE60140545T DE60140545D1 DE 60140545 D1 DE60140545 D1 DE 60140545D1 DE 60140545 T DE60140545 T DE 60140545T DE 60140545 T DE60140545 T DE 60140545T DE 60140545 D1 DE60140545 D1 DE 60140545D1
Authority
DE
Germany
Prior art keywords
alkyl
different
same
group
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60140545T
Other languages
German (de)
English (en)
Inventor
Masahiko Okano
Kazuya Mori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Shinyaku Co Ltd
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Application granted granted Critical
Publication of DE60140545D1 publication Critical patent/DE60140545D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60140545T 2000-03-31 2001-03-30 Expired - Lifetime DE60140545D1 (enExample)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000098874 2000-03-31
JP2000336464 2000-11-02
PCT/JP2001/002822 WO2001072710A1 (en) 2000-03-31 2001-03-30 Heterocycle derivatives and drugs

Publications (1)

Publication Number Publication Date
DE60140545D1 true DE60140545D1 (enExample) 2009-12-31

Family

ID=26589216

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60140545T Expired - Lifetime DE60140545D1 (enExample) 2000-03-31 2001-03-30

Country Status (10)

Country Link
US (1) US6794389B2 (enExample)
EP (1) EP1306372B1 (enExample)
KR (1) KR20020083533A (enExample)
CN (1) CN1242993C (enExample)
AT (1) ATE449084T1 (enExample)
AU (1) AU2001244688A1 (enExample)
CA (1) CA2403605A1 (enExample)
DE (1) DE60140545D1 (enExample)
RU (1) RU2268260C2 (enExample)
WO (1) WO2001072710A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002024666A2 (en) * 2000-09-20 2002-03-28 Merck Patent Gmbh 4-amino-quinazolines
ATE383860T1 (de) * 2000-11-02 2008-02-15 Nippon Shinyaku Co Ltd Chinazolinderivate und -arzneimittel
RU2003130752A (ru) * 2001-03-19 2005-03-10 Ниппон Синяку Ко., Лтд. (Jp) Противозудные средства
US6907295B2 (en) * 2001-08-31 2005-06-14 Biocontrol Medical Ltd. Electrode assembly for nerve control
US7829566B2 (en) * 2001-09-17 2010-11-09 Werner Mederski 4-amino-quinazolines
JP4513566B2 (ja) * 2002-04-26 2010-07-28 日本新薬株式会社 キナゾリン誘導体及び医薬
JP4805234B2 (ja) * 2002-12-16 2011-11-02 キッセイ薬品工業株式会社 経口固形医薬
WO2006074147A2 (en) 2005-01-03 2006-07-13 Myriad Genetics, Inc. Nitrogen containing bicyclic compounds and therapeutical use thereof
JP5129957B2 (ja) 2003-07-03 2013-01-30 ミリアド ジェネティクス, インコーポレイテッド カスパーゼの活性化因子およびアポトーシスの誘発因子としての4−アリールアミノ−キナゾリン
US8309562B2 (en) 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
US20050165032A1 (en) * 2004-01-23 2005-07-28 Norman Mark H. Vanilloid receptor ligands and their use in treatments
US8258145B2 (en) 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
WO2007040231A1 (ja) 2005-10-03 2007-04-12 Nippon Shinyaku Co., Ltd. キナゾリン誘導体及び医薬
RU2314295C2 (ru) * 2006-03-01 2008-01-10 Федеральное Государственное Образовательное Учреждение Высшего Профессионального Образования "Южный Федеральный Университет" 2-гетарилзамещенные 1,3-трополона, способ их получения (варианты) и фармацевтическая композиция антимикробного действия
MX2009012117A (es) * 2007-05-09 2009-11-23 Pfizer Composiciones y derivados heterociclicos sustituidos y su uso farmaceutico como antibacterianos.
EP2017294A1 (de) 2007-07-16 2009-01-21 Sika Technology AG Hitzehärtender Schaum
BRPI0923786C8 (pt) 2008-12-30 2021-05-25 Arqule Inc compostos 5,6-dihidro-6-fenilbenzo(f) isoquinolina-2- amina substituidos e composições farmacêuticas compreendendo ditos compostos
WO2012027495A1 (en) 2010-08-27 2012-03-01 University Of The Pacific Piperazinylpyrimidine analogues as protein kinase inhibitors
SG11201403744YA (en) 2011-12-28 2014-09-26 Fujifilm Corp Novel nicotinamide derivative or salt thereof
WO2024258849A2 (en) * 2023-06-13 2024-12-19 The Trustees Of Indiana University Small molecule antiviral drug treatment for human papillomavirus infections

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3753981A (en) 1970-07-15 1973-08-21 Squibb & Sons Inc 4-amino-2-styrylquinazoline compounds
PT100905A (pt) 1991-09-30 1994-02-28 Eisai Co Ltd Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
JP2657760B2 (ja) 1992-07-15 1997-09-24 小野薬品工業株式会社 4−アミノキナゾリン誘導体およびそれを含有する医薬品
WO1997020821A1 (en) * 1995-12-01 1997-06-12 Novartis Ag Heteroaryl derivatives
EP0973513A4 (en) 1996-10-23 2003-03-19 Zymogenetics Inc COMPILATIONS AND METHOD FOR TREATING BONE DEFICIENCY
CA2226058C (en) 1997-01-30 2008-01-29 F. Hoffmann-La Roche Ag 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives
AR012634A1 (es) 1997-05-02 2000-11-08 Sugen Inc Compuesto basado en quinazolina, composicion famaceutica que lo comprende, metodo para sintetizarlo, su uso, metodos de modulacion de la funcion deserina/treonina proteinaquinasa con dicho compuesto y metodo in vitro para identificar compuestos que modulan dicha funcion
DE69826278T2 (de) 1997-05-30 2005-11-10 Banyu Pharmaceutical Co., Ltd. 2-oxoimidazol-derivate
AU8748798A (en) 1997-08-22 1999-03-16 Kyowa Hakko Kogyo Co. Ltd. 4-aminoquinazoline derivatives
RU2202344C2 (ru) * 1998-03-26 2003-04-20 Джапан Тобакко Инк. Антагонисты ноцицептина, производные амида, аналгетик, способ инициирования антагонистического действия к ноцицептину, способ лечения боли, фармацевтические композиции
RU2003130752A (ru) 2001-03-19 2005-03-10 Ниппон Синяку Ко., Лтд. (Jp) Противозудные средства

Also Published As

Publication number Publication date
CN1242993C (zh) 2006-02-22
KR20020083533A (ko) 2002-11-02
AU2001244688A1 (en) 2001-10-08
RU2002129100A (ru) 2004-02-27
CA2403605A1 (en) 2002-09-18
US6794389B2 (en) 2004-09-21
ATE449084T1 (de) 2009-12-15
RU2268260C2 (ru) 2006-01-20
CN1422255A (zh) 2003-06-04
EP1306372A1 (en) 2003-05-02
US20030119855A1 (en) 2003-06-26
WO2001072710A1 (en) 2001-10-04
EP1306372B1 (en) 2009-11-18
EP1306372A4 (en) 2004-03-17

Similar Documents

Publication Publication Date Title
DE60140545D1 (enExample)
DK0567982T3 (da) Azolforbindelser, deres fremstilling og anvendelse
BR0116539A (pt) Derivados de piridona tendo uma atividade de ligação para o receptor 2 do tipo canabinóide
ZA873593B (en) Site specific alkylating agents
GB9315206D0 (en) Natural amino acid derivatives as metalloproteinase inhibitors
DK1720881T3 (da) 11-hydroxy-5h-(2,1-c)(1,4)benzodiazepin-5-on-derivater som nøglemellemprodukter i fremstilling afc2-substituerede pyrrolobenzodiazepiner
NO20001816L (no) Substituerte, kondenserte heterosykliske forbindelser
DK1312359T3 (da) Anvendelse af 1,3-propandiolforbindelser
DE69109482D1 (en) Pyrimidinnucleosidderivat.
DK0806416T3 (da) Huperzinderivater, deres fremstilling og anvendelse
DE60132484D1 (de) Chinazolinderivate und -arzneimittel
WO2005046672A3 (fr) Utilisation d’inhibiteurs de glucosidase pour une therapie de la mucoviscidose
DK154092D0 (da) Imidazolforbindelser, deres fremstilling og anvendelse
DK0618193T3 (da) Nitrogenholdige, bicycliske derivater som prolyl-endopeptidaseinhibitorer
EP0882721A4 (en) SIALIC ACIDS 2,7-DIDEOXY-7-FLUORO- 2, 3-DIDEHYDRO A QUADRUPLE SUBSTITUTION
DK0649843T3 (da) Thiazolinderivater
EP0222566A3 (en) Stabilised polyolefin composition
TR200003652T2 (tr) Glisin antagonistleri olarak tetrahidrokuinolin türevleri.
NO940026D0 (no) Mono- og bis alkylamino-antra-cykliner
BR8802065A (pt) Composto,processo para a preparacao de um composto,composicao herbicida e processo para combater o crescimento de plantas indesejaveis num local
EP1921063A4 (en) INDOIND CONNECTION, OPTICAL FILTER AND MATERIAL FOR OPTICAL RECORDING
NO20005820L (no) Pyrazolo[1,5-a]pyrimidin-derivater

Legal Events

Date Code Title Description
8364 No opposition during term of opposition